Complete Salvage Surgical Cytoreduction Improves Further Survival of Patients with Late Recurrent Ovarian Cancer
- 31 December 2000
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 79 (3), 344-349
- https://doi.org/10.1006/gyno.2000.5992
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Paclitaxel–Anthracycline Combination Chemotherapy in Relapsing Advanced Ovarian Cancer after Platinum-Based Chemotherapy: A Pilot StudyGynecologic Oncology, 1998
- Analysis of Failures after Negative Second-Look in Patients with Advanced Ovarian Cancer: An Italian Multicenter StudyGynecologic Oncology, 1998
- Secondary Cytoreductive Surgery at Second-Look Laparotomy in Advanced Ovarian Cancer: A Gynecologic Oncology Group StudyGynecologic Oncology, 1997
- Prognostic Significance of Residual Disease in Patients with Stage IV Epithelial Ovarian CancerGynecologic Oncology, 1997
- Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapyEuropean Journal Of Cancer, 1995
- Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective studyCancer, 1995
- Epithelial Ovarian Carcinoma: Principles of Primary SurgeryGynecologic Oncology, 1994
- Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancerEuropean Journal Of Cancer, 1994
- Secondary cytoreductive surgery for recurrent epithelial ovarian cancerGynecologic Oncology, 1989
- Secondary cytoreductive surgery in epithelial ovarian cancer: Nonresponders to first-line therapyGynecologic Oncology, 1989